Ignite Creation Date:
2024-05-06 @ 1:15 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03971422
Status:
COMPLETED
Last Update Posted:
2023-09-05
First Post:
2019-05-29
Brief Title:
A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-03
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-26
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-29
First Submit QC Date:
May 29 2019
Study First Post Date:
2019-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-08-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2022-08-30
Disp First Submit QC Date:
August 30 2022
Disp First Post Date:
2022-08-31
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-10-08
Last Update Post Date:
2023-09-05
Last Update Post Date Type:
ACTUAL